Advancements in Virtual Bioequivalence: A Systematic Review of Computational Methods and Regulatory Perspectives in the Pharmaceutical Industry
Nasser Alotaiq, Doni Dermawan · 2024
Read Advancements in Virtual Bioequivalence: A Systematic Review of Computational Methods and Regulatory Perspectives in the Pharmaceutical Industry by Nasser Alotaiq, Doni Dermawan (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11597508.txt.
Description
Nasser Alotaiq and Doni Dermawan review computer-based drug equivalence testing in a 2024 paper. Before a generic drug can replace a brand one, makers must show the body absorbs both alike. Running that proof in people is slow and costly, so firms increasingly simulate it instead.
The review gathers studies that use body-based computer models to predict absorption and judge equivalence, with a focus on hard-to-copy formulations. It also tracks how regulators in the United States and Europe view such evidence. The models were found to sharpen absorption forecasts and cut the need for human trials. Clear rules on search, selection, and quality checks guided the review. The authors see virtual testing becoming a normal part of drug approval.
Catalog record
| CREATOR | Nasser Alotaiq, Doni Dermawan |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |